Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 26;16(1):186.
doi: 10.1186/s13019-021-01565-0.

Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?

Giuseppe Nasso  1 , Roberto Lorusso  2   3 , Marco Moscarelli  4 , Giuseppe De Martino  5 , Angelo M Dell'Aquila  6 , Arash Motekallemi  6 , Nicola Di Bari  7 , Ignazio Condello  4 , Pasquale Mastroroberto  8 , Giuseppe Santarpino #  4   8   9 , Giuseppe Speziale #  4
Affiliations

Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?

Giuseppe Nasso et al. J Cardiothorac Surg. .

Abstract

Background: The debate on the best treatment strategy for atrial fibrillation (AF) has expanded following the introduction of the so-called "hybrid procedure" that combines minimally invasive epicardial ablation with endocardial catheter ablation. However, the advantage of the hybrid approach over conventional epicardial ablation remains to be established.

Methods: From June 2008 to December 2020, 609 surgical AF ablation procedures through a right minithoracotomy were performed at our institution. From 2008 to 2011, a unipolar radiofrequency (RF) device was used, whereas from 2011 to 2020 a bipolar RF device was used. In addition, between September 2016 and April 2017, 60 patients underwent endocardial completion of epicardial linear ablation. In 30 of these latter patients, surgical isolation of the Bachmann's bundle (BB) was also performed. Starting from 2021, surviving patients at follow-up were asked to undergo electrocardiographic evaluation and left ventricular function assessment and to complete a questionnaire addressing quality of life and predisposing factors for recurrent AF.

Results: The ablation procedure was completed in all patients. Upon discharge, 30 (4.9%) patients showed recurrence of AF, whereas the remaining patients (95.1%) were in sinus rhythm. All patients in whom a hybrid approach was used either with or without BB ablation were discharged in sinus rhythm. After a mean follow-up of 74 months, 122 (20%) patients developed recurrent AF, including 19.9% in whom a unipolar RF device was used, 21% in whom a bipolar RF device was used, 23% who had undergone a hybrid procedure without BB ablation and 3.3% who had undergone a hybrid procedure with BB ablation. On multivariate analysis, reduced left ventricular ejection fraction, worsening of European Heart Rhythm Association symptom class, and cognitive impairment or depression during follow-up were found to be significantly associated with AF recurrence.

Conclusions: Surgical AF ablation through a right minithoracotomy is safe and may allow the creation of additional linear lesions, particularly in the BB. The placement of adjunctive linear lesions in the setting of a hybrid procedure can be more effective in reducing the risk for AF recurrence than isolated surgical ablation or hybrid ablation without the addition of further linear lesions, with no incremental risk to the patient.

Keywords: Catheter ablation of atrial fibrillation; Hybrid ablation of atrial fibrillation; Surgical ablation of atrial fibrillation.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
Atrial fibrillation recurrence by type of ablation procedure. Recurrence rates were 19.9% with unipolar RF ablation, 21% with bipolar RF ablation, 23% with hybrid procedure without adjunctive BB ablation, and 3.3% with hybrid procedure with adjunctive BB ablation
See this image and copyright information in PMC

References

    1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J. 2020;42:373–498. doi: 10.1093/eurheartj/ehaa612. - DOI - PubMed
    1. Muneretto C, Bisleri G, Rosati F, Krakor R, Giroletti L, Di Bacco L, et al. European prospective multicentre study of hybrid thoracoscopic and transcatheter ablation of persistent atrial fibrillation: the HISTORIC-AF trial. Eur J Cardiothorac Surg. 2017;52(4):740–745. doi: 10.1093/ejcts/ezx162. - DOI - PubMed
    1. Mohanty S, Di Biase L, Mohanty P, Trivedi C, Santangeli P, Bai R, et al. Effect of periprocedural amiodarone on procedure outcome in patients with longstanding persistent atrial fibrillation undergoing extended pulmonary vein antrum isolation: results from a randomized study (SPECULATE) Heart Rhythm. 2015;12(3):477–483. doi: 10.1016/j.hrthm.2014.11.016. - DOI - PubMed
    1. Nasso G, MoscarelliM FK, Zebele C, Iacopino S, Fiore F, et al. Mid-term performance of bipolar radiofrequency ablation for isolated atrial fibrillation through a right minithoracotomy. Semin Thorac Cardiovasc Surg. 2017;29(2):160–172. doi: 10.1053/j.semtcvs.2017.01.005. - DOI - PubMed
    1. Muneretto C, Bisleri G, Bontempi L, Cheema FH, Curnis A. Successful treatment of lone persistent atrial fibrillation by means of a hybrid thoracoscopic-transcatheter approach. Innovations (Phila) 2012;7(4):254–258. doi: 10.1097/imi.0b013e31826f0462. - DOI - PubMed